Effect of Mild and Moderate Hepatic Impairment (defined by Child-Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics.

Hamim Zahir,Jonathan Greenberg,Ching Hsu,Thomas C. Marbury,Kenneth C. Lasseter, Li-An Xu,William D. Tap,John H. Healey,Silvia Stacchiotti,Frank LaCreta

Journal of clinical pharmacology（2022）

Cited 2|Views20
No score
Key words
Child-Pugh,hepatic impairment (HI),mild HI,moderate HI,NCI-ODWG,pexidartinib,pharmacokinetics,tenosynovial giant cell tumor (TGCT),ZAAD-1006A
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined